SNN - Smith & Nephew plc
37.76 -0.61 (-1.59%)
Pre-Market: 7:17AM EST
| Previous Close | 38.60 |
| Open | 38.70 |
| Bid | 37.93 x 1400 |
| Ask | 37.97 x 1200 |
| Day's Range | 38.16 - 38.73 |
| 52 Week Range | 32.22 - 39.85 |
| Volume | 465,185 |
| Avg. Volume | 565,560 |
| Market Cap | 16.611B |
| Beta (3Y Monthly) | 0.50 |
| PE Ratio (TTM) | 23.42 |
| EPS (TTM) | 1.64 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.56 (1.48%) |
| Ex-Dividend Date | 2018-10-04 |
| 1y Target Est | 42.00 |
- Insider Monkey•5 days ago
Here is What Hedge Funds Think About CNH Industrial NV (CNHI)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth depends on it. Regardless of the various methods used by elite investors like David Tepper and Dan Loeb, […]
- Simply Wall St.•10 days ago
A Look At The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
Does the December share price for Smith & Nephew plc (LON:SN.) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value by taking the foreast future cash flows Read More...
- PR Newswire•28 days ago
Smith & Nephew Presents Excellent Results for JOURNEY™ II Total Knee at the 2018 American Association of Hip and Knee Surgeons
MEMPHIS, Tenn. , Nov. 16, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, presented a number of compelling clinical outcomes around its flagship JOURNEY ...
- Simply Wall St.•last month
Looking At Smith & Nephew plc (LON:SN.) From All Angles
Attractive stocks have exceptional fundamentals. In the case of Smith & Nephew plc (LON:SN.), there’s is a notable dividend payer that has been able to sustain great financial health over Read More...
Reuters•last monthBrexit-fuelled pound surge weighs on FTSE, BT earnings shine
UK shares fell on Thursday, snapping three days of gains, even after strong trading updates from BT and Smith & Nephew as optimistic news on Brexit led to a surge in the pound which acts as an accounting drag on blue chips' foreign revenues. London's FTSE 100 (.FTSE) ended down 0.5 percent, underperforming its European peers as sterling jumped 1.4 percent for it biggest one-day rise since January after reports that a deal is nearly done to give London-based financial services access to European Union markets after Brexit. The currency was also briefly boosted after the Bank of England held interest rates unchanged as expected but hinted at slightly faster future rises if Brexit goes smoothly.
- Reuters•last month
Demand for new hips to boost Smith & Nephew profit margin
Britain's Smith & Nephew (SN.L) expects its trading profit margin to be higher this year than last on a better performance for its hips franchise, boosting its shares. Shares in the artificial hips and knees maker jumped 5.2 percent to 1,340 pence in early trading on Thursday after the positive update. "Underlying growth was solid, and there was a welcome return to good growth in the hips business," Bernstein analysts said.
- Simply Wall St.•2 months ago
What Does Smith & Nephew plc’s (LON:SN.) PE Ratio Tell You?
This article is intended for those of you who are at the beginning of your investing journey and want to learn about the link between company’s fundamentals and stock market Read More...
- PR Newswire•2 months ago
Two new studies demonstrate INTERTAN™ Intertrochanteric Antegrade Nail improves patient outcomes and lowers healthcare costs when treating hip fractures
LONDON , Oct. 17, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announced at the Orthopaedic Trauma Association Annual Meeting in Orlando, FL USA ...
- Simply Wall St.•2 months ago
What Investors Should Know About Sunniva Inc’s (CNSX:SNN) Financial Strength
While small-cap stocks, such as Sunniva Inc (CNSX:SNN) with its market cap of CA$169m, are popular for their explosive growth, investors should also be aware of their balance sheet to Read More...
- Simply Wall St.•2 months ago
Income Investors Should Know The Smith & Nephew plc (LON:SN.) Ex-Dividend Date
Shares of Smith & Nephew plc (LON:SN.) will begin trading ex-dividend in 4 days. To qualify for the dividend check of US$0.14 per share, investors must have owned the shares Read More...
- Simply Wall St.•3 months ago
Do Institutions Own Shares In Smith & Nephew plc (LON:SN.)?
If you want to know who really controls Smith & Nephew plc (LON:SN.), then you’ll have to look at the makeup of its share registry. Generally speaking, as a companyRead More...
- Simply Wall St.•4 months ago
Can Smith & Nephew plc (LON:SN.) Continue To Outperform Its Industry?
The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to start learning about core conceptsRead More...
Market Realist•4 months agoMDT’s Minimally Invasive Therapies’ Fiscal Q1 2019 Performances
In the first quarter of fiscal 2019, Medtronic’s (MDT) Minimally Invasive Therapies Group reported revenue of $2.1 billion compared to $2.5 billion in the fiscal first quarter of 2018, reflecting a ~17% YoY (year-over-year) fall.
- Benzinga•4 months ago
AxisWire: Cannabis Companies Are Moving To Canada, Its Friendlier Legal Climate
Canada possesses more short-term advantages for going public, as cannabis business owners benefit from operating in a market that carries little legal risk. “Sure, nine states have legalized recreational cannabis, but it’s still federally illegal. Canadian company Sunniva, Inc. (CNSX: SNN) plans to obtain licensing in both Canada and California, making it one of the first cannabis companies operating in both regions.
- Reuters•5 months ago
Smith & Nephew buoyed by recovery in U.S. market
Smith & Nephew's new chief executive confirmed the company's full-year guidance on Thursday after improvement in its U.S. market helped revenues for the artificial hip and knee maker to recover from a tough start to the year. Smith & Nephew (SN.L) said underlying revenue growth for the year was still expected to be 2-3 percent, after it cut its outlook in its previous trading statement in May, one of the last acts of its previous CEO. New boss Namal Nawana said that while Europe remained soft, there had been improvement in the United States, where the company derives about half of its revenues.
- PR Newswire•5 months ago
JOURNEY™ II BCS Knee System demonstrates improved patient outcomes and lower healthcare costs
LONDON , July 25, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announced positive clinical results concerning its JOURNEY™ II Bi-Cruciate Stabilized ...
- ACCESSWIRE•5 months ago
Today’s Free Research Reports Coverage on Neovasc and Three More Healthcare Stocks
Under assessment this morning are these four equities: Myomo Inc. (NYSE AMER: MYO), Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), and Insulet Corp. (NASDAQ: PODD). All you have to do is sign up today for this free limited time offer by clicking the link below.
- PR Newswire•5 months ago
UK’s NICE Publishes a Medtech Innovation Briefing on PICO™ for the Prophylactic Use in Surgically Closed Incisions to Reduce Surgical Site Complications
LONDON and NEW YORK , July 3, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN) (NYSE: SNN), the global medical technology business, announces that the UK's National Institute for Health and Care Excellence ...
- ACCESSWIRE•6 months ago
Neovasc and Three Additional Medical Appliances & Equipment Stocks on Our Research Desk’s Radar
This Monday, WallStEquities.com has initiated reports coverage on the following Medical Appliances & Equipment equities: Neovasc Inc. (NASDAQ: NVCN), Smith & Nephew PLC (NYSE: SNN), Accuray Inc. (NASDAQ: ARAY), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX). All you have to do is sign up today for this free limited time offer by clicking the link below.
- Simply Wall St.•6 months ago
Is Smith & Nephew plc’s (LON:SN.) Balance Sheet Strong Enough To Weather A Storm?
The size of Smith & Nephew plc (LSE:SN.), a UK£11.91B large-cap, often attracts investors seeking a reliable investment in the stock market. Big corporations are much sought after by risk-averseRead More...
- Reuters•7 months ago
Outgoing Smith & Nephew CEO signs off with a downgrade
Smith & Nephew downgraded its revenue and profit forecasts after a weak first quarter on Thursday, days before Chief Executive Olivier Bohuon will end his seven-year tenure at the artificial knee and hip maker. It also lowered trading profit forecasts, predicting a margin at or above the level achieved last year rather than the 30-70 basis point growth it had targeted. Bohuon, who steps down on Monday, said the business had seen a "mixed performance" in the quarter to end-March, with established markets like the United States and Europe down 2 percent on an underlying basis and emerging markets up 9 percent, resulting in a flat result overall.
